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Abstract 
Background: Genome mining approaches predict dozens of biosynthetic gene clusters in each of the filamentous 
fungal genomes sequenced so far. However, the majority of these gene clusters still remain cryptic because they are 
not expressed in their natural host. Simultaneous expression of all genes belonging to a biosynthetic pathway in a 
heterologous host is one approach to activate biosynthetic gene clusters and to screen the metabolites produced 
for bioactivities. Polycistronic expression of all pathway genes under control of a single and tunable promoter would 
be the method of choice, as this does not only simplify cloning procedures, but also offers control on timing and 
strength of expression. However, polycistronic gene expression is a feature not commonly found in eukaryotic host 
systems, such as Aspergillus niger.
Results: In this study, we tested the suitability of the viral P2A peptide for co-expression of three genes in A. niger. 
Two genes descend from Fusarium oxysporum and are essential to produce the secondary metabolite enniatin (esyn1, 
ekivR). The third gene (luc) encodes the reporter luciferase which was included to study position effects. Expression 
of the polycistronic gene cassette was put under control of the Tet-On system to ensure tunable gene expression in 
A. niger. In total, three polycistronic expression cassettes which differed in the position of luc were constructed and 
targeted to the pyrG locus in A. niger. This allowed direct comparison of the luciferase activity based on the position 
of the luciferase gene. Doxycycline-mediated induction of the Tet-On expression cassettes resulted in the production 
of one long polycistronic mRNA as proven by Northern analyses, and ensured comparable production of enniatin in 
all three strains. Notably, gene position within the polycistronic expression cassette matters, as, luciferase activity was 
lowest at position one and had a comparable activity at positions two and three.
Conclusions: The P2A peptide can be used to express at least three genes polycistronically in A. niger. This approach 
can now be applied to heterologously express entire secondary metabolite gene clusters polycistronically or to co-
express any genes of interest in equimolar amounts.
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Background
The filamentous fungus Aspergillus niger is one of the 
main microbial cell factories used in biotechnology for 
the production of various organic acids, proteins and 
enzymes [1, 2]. In 2014, A. niger was re-engineered to 
produce the secondary metabolite enniatin heterolo-
gously in amounts comparable to the natural producer, 
Fusarium oxysporum was shown [3]. This study not 
only paved the way for establishing A. niger as an indus-
trial producer of homologous or heterologous natural 
products with pharmaceutical applications, but also 
enabled studies aiming at overexpression of fungal chi-
meric enzymes synthesising new-to-nature compounds. 
This was impossible in bacterial or yeast expression sys-
tems due to low expression levels [4]. Given the recent 
advances in fungal genome editing, sophisticated genetic 
and metabolic engineering approaches are now fea-
sible for A. niger. Various selection markers are avail-
able for A. niger [5, 6], the split marker approach [7] is 
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commonly used to delete genes, and CRISPR/Cas9 has 
been experimentally validated in numerous filamentous 
fungal systems [8, 9]. However, controlled co-expression 
of a set of genes, or entire pathways, is still technically 
challenging and has not been shown in A. niger to date. 
In 2014, two publications have reported the successful 
use of a viral peptide for polycistronic gene expression in 
fungi. Beekwilder et  al. established it for the yeast Sac-
charomyces cerevisiae to produce β-carotene and Unkles 
et  al. were able to express the penicillin gene cluster, 
encoding the ACV synthetase (pcbAB), isopenicillin 
N synthase (pcbC) and isopenicillin N acyltransferase 
(penDE) in the filamentous fungus Aspergillus nidulans 
using the P2A peptide [10, 11]. The use of the viral 2A 
peptide for polycistronic gene expression in eukaryotes 
was first described in 2004 [12], where three different 2A 
sequences (E2A—equine rhinitis A virus, F2A—foot-and-
mouth disease virus and T2A—Thoseaasigna virus) were 
used to assemble four transmembrane proteins of the 
T-cell receptor CD3 complex.
The underlying principle of 2A peptide-based co-trans-
lation is called the “stop-carry on mechanism”. In brief, 
the corresponding DNA sequence of an about 20 amino 
acid long 2A peptide is placed between the genes for co-
expression (Fig.  1a). During transcription, a long, poly-
cistronic mRNA is formed, which is used as a template 
for ribosome-mediated translation. When the ribosome 
translates the 2A sequence, it skips the formation of a 
peptide bond between the last two amino acids (glycine, 
proline) but continues translation. As a result, equimolar 
amounts of different proteins become translated from a 
single transcript [13]. Kim et al. analysed the functional-
ity of four different 2A sequences (E2A, F2A, T2A and 
P2A—Porcine teschovirus) in different organisms and 
concluded that the P2A peptide has the highest cleav-
age efficiency [14]. In addition, the system was proven to 
work in nematodes [15] and Pichia pastoris. In the lat-
ter system, nine genes were co-expressed from a bidirec-
tional promoter to produce carotenoids and violaceins 
[16]. Notably, proteins expressed polycistronically by use 
Fig. 1 Tet-On based P2A-mediated polycistronic expression system for A. niger. a Protein sequences of the P2A peptide and the putatively non-
functional P2A peptide are given. For the latter, the final C-terminal amino acid proline was exchanged for an alanine. General design of the Tet-On 
system has been described earlier [26]. Order of genes and abbreviations used for the A. niger transformants made are described in the main text. 
b Schematic illustration of the proteins produced by ribosomal translation and position of the 2A added tags at the N- or C-terminal ends of the 
proteins
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of any of the 2A peptides become modified, which in turn 
might impact their activities. They carry an additional 
proline on their N-terminus and the remaining amino 
acids of the 2A peptide at their C terminus (Fig. 1b). A 
potential negative effect of such 2A peptide-mediated 
protein modification was most recently reported for 
the filamentous fungus Trichoderma reesei. Bicistronic 
expression of the enhanced green fluorescent protein 
(eGFP) and a cellobiohydrolase using the F2A peptide 
allowed detection of a functional eGFP when it was 
expressed at the second position, but not at the first [17].
In the present study, we aimed to adapt and evalu-
ate the P2A system for A. niger by co-expressing three 
different genes. We expressed luciferase and two genes 
required for production of the secondary metabolite 
enniatin (ekivR, esyn1) polycistronically under control of 
the inducible Tet-On system. The latter two genes origi-
nate from F. oxysporum, esyn1 encodes the nonribosomal 
peptide synthetase ESYN, and ekivR the ketoisovalerate 
reductase KivR, which is required for synthesis of the 
precursor molecule d-hydroxyisovalerate [3]. Our results 
show that polycistronic gene expression did indeed allow 
expression of all three proteins and the successful pro-
duction of enniatin. The data furthermore demonstrate 
that, in the case of luciferase, gene position within the 
polycistronic construct has important consequences for 
luciferase activity.
Results and discussion
Engineering of strains heterologously expressing 
polycistronic expression cassettes
In order to test and evaluate the functionality of the P2A 
peptide in A. niger and to study potential position effects 
within the expression cassette, three different polycis-
tronic gene expression cassettes were designed. By plac-
ing the luciferase gene at position one, two and three, 
and by keeping the order of ekivR and esyn1 constant, the 
final expression cassettes had the order LKE, KLE and 
EKL, respectively, whereby ‘L’ stands for luciferase, ‘K’ 
for ketoisovalerate reductase and ‘E’ for enniatin synthase 
(Fig.  1). As a negative control for construct LKE, we 
furthermore designed a fourth polycistronic construct 
(L*K*E*), in which a putatively non-functional P2A pep-
tide was included. There, the final proline was exchanged 
for an alanine. In vitro and in vivo data have shown that 
this leads to a non-functional 2A peptide in S. cerevisiae 
causing translation of a fusion protein [10, 13]. All poly-
cistronic gene cassettes were put under control of the 
Tet-On system and targeted to the pyrG locus of A. niger. 
Details on cloning and selection of A. niger transformants 
each carrying a single copy of the respective plasmid at 
the pyrG locus are given in Additional file 1. Strains that 
have been selected for further analyses are summarised 
in Table 1.
Luciferase activity and enniatin B production
To analyse the luciferase activity, luminescence was 
measured in A. niger transformants which were cultivated 
in microtiter plates in biological triplicates. In addition to 
the recipient strain (‘R’) and strains carrying the respec-
tive polycistronic construct, a control strain expressing 
the luciferase gene monocistronically under the Tet-On 
promoter system and targeted to the pyrG locus was 
included in the analyses (strain ‘L’, [18]). As expected, all 
strains except for the recipient strain showed an increase 
in luminescence during the cultivation and only in the 
presence of the inducing molecule doxycycline (Fig. 2 and 
data not shown). Surprisingly, luminescence also contin-
uously increased in the L*K*E strain though at very low 
levels. This might suggest that, in contradiction to data 
reported for S. cerevisiae, the mutated version of P2A is 
still recognised by ribosomes in A. niger but with low effi-
ciency and/or that a long fusion protein has been formed 
consisting of all three enzymes partly allowing luciferase 
to be functional. It is well-known that luciferase can 
function in cis when fused to other proteins [19], hence 
both events are possible and not mutually exclusive. As 
depicted in Fig.  2, the strains L, KLE and KEL cluster 
together according to their luminescence profile in time, 
whereas strain LKE, where luciferase is placed at position 
Table 1 Aspergillus niger strains used in this study
Strain name Relevant genotype/description Abbreviation References
AB1.13 prtT13, pyrG378 R [22]
ÖV4.10 Tet-On-esyn1-TtrpC, pyrG+, single copy; PgpdA-ekivR-TtrpC-amdS E + K [3]
XM1.7 Tet-On-luc-TtrpC, pyrG+, single copy L [18]
TS38.3 Tet-On-luc-P2A-ekivR-P2A-esyn1-TtrpC, pyrG+, single copy LKE This study
TS39.4 Tet-On-luc-P2A∗-ekivR-P2A∗-esyn1-TtrpC, pyrG+, single copy L*K*E This study
TS40.4 Tet-On-ekivR-P2A-luc-P2A-esyn1-TtrpC, pyrG+, single copy KLE This study
TS41.13 Tet-On-ekivR-P2A-esyn1-P2A-luc-TtrpC, pyrG+, single copy KEL This study
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one within the polycistronic cassette, shows only 27% of 
the luminescence compared to strains KLE and KEL. This 
observation, indicates on the one hand that an additional 
proline at the N-terminus is beneficial for luciferase 
activity, whereas the addition of 21 amino acids to the 
C-terminus does not interfere with luminescence activity 
and/or stability. On the other hand, it can be concluded 
that expression levels and/or enzyme activity of the poly-
cistronic gene cassettes can be as high as the ones from 
a strain expressing luciferase monocistronically. Notably, 
the different activities of luciferase at the three positions 
imply that the P2A-mediated addition of amino acids at 
the N- and C-terminus of the proteins of interest need 
to be analysed individually and cannot be predicted. In 
the case of bicistronic expression of eGFP and cellobio-
hydrolase in T. reesei, eGFP placed at position one (con-
sequently modified at its C-terminus) showed reduced 
stability and/or fluorescence compared to its placement 
at position two. No position effects were observed for 
cellobiohydrolase [17]. Still, these effects do not prevent 
efficient application of polycistronic gene expression in a 
host of interest.
The additional C-terminal amino acids could poten-
tially be removed by inclusion of a furin cleavage site. 
This has been successfully demonstrated in a mammalian 
cell line (HEK293) producing the heavy and light chain 
of an antibody using the F2A peptide. A higher antibody 
concentration was measured in the serum when the 
cleavage site was present [20].
Concomitant with luciferase activity, the production of 
enniatin B was analysed in two different media varying in 
their glucose concentration. The purpose of the experi-
ment was not to analyse the impact of different positions 
within the polycistronic cassette, but to provide proof-of-
principle that secondary metabolite production is gen-
erally possible via P2A-mediated co-translation of the 
biosynthetic genes esyn1 and ekivR in A. niger. As a con-
trol, a strain expressing the enniatin synthetase under the 
Tet-On promoter system and the ketoisovalerate reduc-
tase gene constitutively under the gpdA promoter was 
used [3]. The expression and location of the esyn1 gene in 
this strain is comparable to the strains with the polycis-
tronic cassettes because it is present as single copy at the 
pyrG locus. However, this A. niger strain contains multi-
ple copies of the ekivR gene in the genome [3] and is thus 
likely expressing more KivR enzyme compared to the 
strains expressing the ekivR gene polycistronically. The 
corresponding results of biological triplicate experiments 
are summarised in Table  2. At both glucose concentra-
tions all strains except for the recipient strain produced 
enniatin B. Notably, all strains expressing ekivR and esyn1 
polycistronically produced less compared to the strain 
expressing them monocistronically, in case of 1% glucose, 
approximately 2.4-fold less. This suggests that the KivR 
enzyme catalyses the rate-limiting step in the enniatin 
biosynthesis, a hypothesis which needs to be verified in 
future experiments. Interestingly, the strain with a puta-
tively non-functional P2A did produce enniatin B as well 
Fig. 2 Analysis of reporter activity. Luminescence data of the indicated strains cultivated in microtiter plates and expressing the luciferase gene 
mono- or polycistronically, n = 3. For experimental details, see “Methods” section
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and concentrations in case of 1% glucose were about 1.5-
fold less compared to the strain with a functional P2A 
(LKE). At 5% glucose, the difference among the strains 
expressing the genes required for enniatin B production 
polycistronically was more pronounced (Table 2). Strain 
KEL produced the most and the putatively non-func-
tional P2A about 2.5-fold less compared to its functional 
analogue. Again the strain expressing the two genes 
monocistronically produced approximately 2.7-fold more 
enniatin B. These data unambiguously show that enni-
atin B can be produced by expressing genes required for 
its synthesis polycistronically in A. niger and imply that 
the efficiency of enniatin synthesis might be improved 
by genetic and/or metabolic engineering approaches of 
the KivR reaction step. The fact that the putatively non-
functional P2A showed luciferase activity as measured by 
luminescence and enniatin B production indicates that 
either the fusion protein is active at low efficiency, that 
the non-functional P2A is processed as well, that pro-
teases might cleave the resulting fusion protein and/or a 
combination thereof.
Validation of polycistronic gene expression on mRNA 
and protein level
In order to prove the presence of one long mRNA and 
single proteins for the polycistronic strains, Northern 
and Western blot analyses were conducted. One long, 
mRNA could indeed be detected and differed signifi-
cantly in size compared to RNA isolated from a strain 
expressing the luciferase monocistronically (Fig.  3). For 
Western analyses, a monoclonal antibody against lucif-
erase was used to verify the presence of luciferase and 
analyse the formation of a fusion protein. As expected, 
no luciferase signal could be detected for the recipient 
strain, whereas all other strains showed a signal between 
55 and 70 kDa (data not shown) with an expected size of 
61 kDa for luciferase. Surprisingly, none of the polycis-
tronic expression strains showed a band above 70 kDa, 
suggesting high efficiency processing of the P2A pep-
tide. However, in case of the non-functional P2A a fusion 
protein was expected. Previous reports in S. cerevisiae as 
well as in vitro studies demonstrated that mutation of the 
final proline to an alanine prevents processing of the 2A 
peptide, therefore resulting in the production of a fusion 
protein [10, 13]. In another study, 52 2A mutants were 
analysed and very little flexibility was seen in  vitro as 
Table 2 Enniatin B production of strains expressing ekivR and esyn1 mono- and polycistronically using 1 and 5% of glu-
cose as carbon source
Experiments were done in biological triplicates. Enniatin was extracted from the freeze-dried solid fraction
Glucose concentration (%) Strain name Abbreviation Enniatin B concentration (mg/g dry solids)
1 AB1.13 R 0 ± 0
1 ÖV4.10 K + E 4.72 ± 1.06
1 TS38.3 LKE 1.73 ± 0.52
1 TS39.4 L*K*E 1.14 ± 0.19
1 TS40.4 KLE 2.07 ± 0.33
1 TS41.13 KEL 2.05 ± 0.36
5 AB1.13 R 0 ± 0
5 ÖV4.10 K + E 29.33 ± 1.64
5 TS38.3 LKE 7.81 ± 1.33
5 TS39.4 L*K*E 3.13 ± 0.57
5 TS40.4 KLE 9.19 ± 1.00
5 TS41.13 KEL 15.41 ± 4.07
Fig. 3 Verification of mono-and polycistronic gene expression using 
Northern analysis. A fragment of the luciferase gene was used as a 
probe to detect luc mRNA in all strains. Results are exemplarily shown 
for the strains KEL and L in biological triplicates. Each sample was 
applied twice. rRNA bands are shown as a loading control. Note that a 
double band in the L sample is indicative for the two polyadenylation 
sites present in the trpC terminator as described earlier [27]. These 
two bands are not indistinguishable in the KEL sample due to the 
large size of the polycistronic mRNA. For details on the abbreviations 
the reader is referred to Table 1
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well as in S. cerevisiae, especially for the last nine amino 
acids [21]. Still, it is conceivable that this is not the case 
for A. niger. Alternatively it might be that in case of the 
non-functional P2A, proteases from A. niger cleave the 
fusion protein. A. niger is well-known for high-level pro-
tease production expression, even in the recipient strain 
used in this study, which is deficient in a transcriptional 
regulator reducing the expression of extracellular pro-
teases [22]. Therefore, it might be possible that detection 
of unprocessed protein is not possible because endog-
enous proteases cleave them. To analyse this, a different 
antibody would have to be used. Antibodies for ketois-
ovalerate reductase or enniatin synthetase are not com-
mercially available, the only option would be the use of a 
2A antibody. However, no controls expressing the genes 
monocistronically can then be used, unless they are 
tagged with the required amino acids.
Conclusions
In this study, we proved that the P2A-mediated poly-
cistronic gene expression is possible in A. niger. We 
were interested in whether or not the position of a gene 
within this construct matters and therefore expressed the 
reporter gene luciferase at position one, two and three. 
In addition, two genes required for enniatin produc-
tion were expressed. We were able to show that position 
indeed matters for luciferase, as its activity was lowest at 
position one. We could furthermore demonstrate that the 
secondary metabolite enniatin can be produced polycis-
tronically which provides proof-of-concept that polycis-
tronic secondary metabolite biosynthesis is possible in A. 
niger.
Methods
Molecular methods
The 2A peptide published in 2011 by Kim et  al. was 
codon optimised for A. niger using the website http://
www.kazusa.or.jp/codon/ and ordered as primer dimers 
[14, 23]. Genes of interest (luc, esyn, ekivR) were ampli-
fied with the Q5 proof-reading polymerase according to 
the manufacturer instructions using primers with 15–18 
overlapping base pair regions. Plasmids were constructed 
using the Gibson assembly reaction [24]. Details on the 
reaction mix are described in reference [18]. For trans-
formation of Escherichia coli TOP10 cells 25 μl of com-
petent cells were mixed with 3 μl of the Gibson reaction. 
Ampicillin at a concentration of 50 μg/ml was used for 
selection. Plasmids were analysed for correct assembly by 
restriction analysis and sequencing of overlapping base 
pair regions of the assembled fragments. In addition, 
PCR products containing the P2A fragments amplified 
from strain TS39.4 were analysed by sequencing to prove 
presence of the alanine coding codon. All primers used 
and details on the assembly can be found in Additional 
file  1. All polycistronic expression cassettes were trans-
formed into the pyrG− recipient strain AB1.13 [22] and 
transformants were screened based on uridine prototro-
phy. A. niger transformation, selection procedures and 
fungal chromosomal DNA isolation were done according 
to Arentshorst et al. [25]. RNA was isolated from freeze 
dried biomass (24  h grown in complete medium with 
20  μg/ml doxycycline) using  TRIzol™ (Thermo Fisher). 
Southern and Northern analysis was done on a nylon 
membrane (Roth) using DIG labelled probes and CDP-
Star® (Sigma-Aldrich) as a substrate. The Riboruler High 
range (Thermo Fisher) was used as RNA ladder.
Strains and cultivation conditions
Escherichia coli TOP10 strains were grown in LB 
medium, supplemented with 1.5% agar-agar and ampicil-
lin when necessary, at 37 °C. A. niger strains were grown 
at 30  °C using complete or minimal medium supple-
mented with 1 mM uridine where necessary. For details 
on medium composition the reader is referred to Arent-
shorst et  al. [25]. For induction 20 μg/ml doxycycline 
hyclate (Sigma-Aldrich) was used. Biomass was separated 
from medium by vacuum filtration. Cultures grown for 
enniatin B determination were supplemented with 10 g/l 
talcum to ensure similar growth morphologies, contain-
ing 1 or 5% (w/v) glucose, which were induced 16 h post 
inoculation and grown at 26 °C [3]. For protein extraction 
samples were induced 8 h post inoculation and allowed 
to grow for 24 h if not specified otherwise.
Protein extraction and analysis
Proteins were extracted from 10 mg ground freeze dried 
biomass using 100 μl sample loading dye diluted with 50 
mM sodium phosphate buffer pH7 (4× loading dye: 40% 
glycerol, 0.08% bromophenol blue, 8% SDS, 4% 2-mer-
captoethanol, 50 mM EDTA, 200 mM Tris-HCl pH 6.8). 
Samples were immediately boiled for 5  min at 95  °C. 
Solids were separated by centrifugation at 19,090×g for 
5 min. Samples were run on a 5–15% (w/v) gradient SDS-
PAGE. Proteins were blotted onto a PVDF membrane 
(Roth). The monoclonal Luci17 anti-luciferase primary 
antibody (Thermo Fisher, diluted 1:3000) was used. This 
antibody was detected with an anti-mouse-HRP conju-
gated antibody (Dako, diluted 1:3000). Primary and sec-
ondary antibody incubations were done in PBS-T (137 
mM NaCl, 2.7 mM KCl, 1 mM Na2HPO4, 0.2 mM KH2
PO4, 0.1% Tween-20) supplemented with 5% powdered 
milk. Incubation times were 16 h at 4 °C for the primary 
and 1 h at room temperature for the secondary antibody. 
The WesternBright kit (Biozym) was used as a substrate 
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for the chemiluminescence reaction and signals were 
detected with the  ChemiDoc™MP Imaging System (Bio-
rad) using the Image Lab software.
Luminescence assay in microtiter plates
Luciferase activity was determined by measuring biolu-
minescence in triplicate in 96 well plates. There, 200 μl 
of complete medium supplemented with 1 mM uridine 
were mixed with 2.7 μl luciferin (25 mM, Promega) and 
2  μg doxycycline. Wells were inoculated with 10 μl of a 
 106  spores/ml suspension. The luminescence in counts 
per second (cps) was detected by a photomultiplier tube 
using a  Victor3™ Perkin Elmer plate reader. Optical 
density (OD) was measured at 595 nm using the same 
instrument.
Enniatin B determination
The freeze dried solid fraction (biomass and talcum) was 
ground and approximately 25 mg were mixed with 1 ml of 
methanol. This mixture was incubated at room tempera-
ture for 1 h at 500 rpm. Solids were separated by centrifu-
gation at 19,090×g for 15 min. Samples were analysed on 
a Bruker ultrafleXtremeTM equipped with a smartbeam 
II laser, in positive linear mode and diluted where nec-
essary. CHCA (α-cyano-4-hydroxycinnamic acid, Sigma 
Aldrich) was used as a matrix at a concentration of 20 
mg/ml in an acetonitrile-water mixture (1:1) acidified 
with formic acid (1%). Acetonitrile and formic acid were 
purchased at VWR. Deuterated enniatin, kindly provided 
by Lennart Richter (TU Berlin), was used as an internal 
standard and added to the matrix at a concentration of 
5 μg/ml. One μl sample was mixed with 1  μl of matrix, 
applied onto the polished sample target and allowed to 
dry. Calibration was done using a peptide standard mix-
ture from Bruker with the following [M+H]+ values: 
angiotensin II (1046.5418), angiotensin I (1296.6848), 
substance P (1347.7354), bombesin (1619.8223), ACTH 
clip 1–17 (2093.0862), ACTH clip 18–39 (2465.1983), 
somatostatin 28 (3147.4710). Spectra were recorded in 
a mass range of 500–3000 Da. The laser was used at a 
50% intensity, with a frequency of 2 kHz. 100–200 shots 
were used to ionise the matrix-sample mixture. Analy-
sis was done using the flex Analysis 3.4 software from 
Bruker Daltonik GmbH. The concentration of enniatin 
B (cennB) was calculated using the following formula and 
automated integration of the sodium adduct of enni-
atin B (ennB) as well as the deuterated internal standard 
(deut-ennB):
cennB =
A([M + Na]
+
ennB
)
A([M + Na]
+
deut−ennB
)
· cdeut−ennB.
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